BrightPath Biotherapeutics Co (TSE:4594) Other Stockholders Equity: 円20.27 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4594 BrightPath Biotherapeutics Co Ltd TSE:4594
34 GF Score
Price 円51.00
! 3 Warning Signs
View Full Analysis

What is BrightPath Biotherapeutics Co Other Stockholders Equity?

BrightPath Biotherapeutics Co TSE:4594 -1.92% 34 Other Stockholders Equity is 円20.27 Mil as of Mar. 2026. GuruFocus rates TSE:4594 with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

BrightPath Biotherapeutics Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was 円20.27 Mil.

BrightPath Biotherapeutics Co's quarterly Other Stockholders Equity increased from Sep. 2025 (円20.27 Mil) to Dec. 2025 (円21.56 Mil) but then declined from Dec. 2025 (円21.56 Mil) to Mar. 2026 (円20.27 Mil).

BrightPath Biotherapeutics Co's annual Other Stockholders Equity declined from Mar. 2024 (円22.84 Mil) to Mar. 2025 (円21.58 Mil) and declined from Mar. 2025 (円21.58 Mil) to Mar. 2026 (円20.27 Mil).

BrightPath Biotherapeutics Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for BrightPath Biotherapeutics Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightPath Biotherapeutics Co Other Stockholders Equity Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.94 20.27 22.84 21.58 20.27

BrightPath Biotherapeutics Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.84 20.27 21.56 20.27 4.93
TSE:4594
34GF Score
BrightPath Biotherapeutics Co Ltd TSE:4594
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BrightPath Biotherapeutics Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円20.27 Mil mean?
BrightPath Biotherapeutics Co (TSE:4594) has a Other Stockholders Equity of 円20.27 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BrightPath Biotherapeutics Co and its competitors.
Is BrightPath Biotherapeutics Co's Other Stockholders Equity too high?
BrightPath Biotherapeutics Co's current Other Stockholders Equity is 円20.27 Mil. Overall, BrightPath Biotherapeutics Co has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BrightPath Biotherapeutics Co's Other Stockholders Equity compare to VRTX and REGN?
BrightPath Biotherapeutics Co's Other Stockholders Equity of 円20.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BrightPath Biotherapeutics Co and its competitors. BrightPath Biotherapeutics Co's current Other Stockholders Equity is 円20.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrightPath Biotherapeutics Co stock overvalued right now?
BrightPath Biotherapeutics Co (TSE:4594) has a current Other Stockholders Equity of 円20.27 Mil. The current Other Stockholders Equity is 円20.27 Mil. BrightPath Biotherapeutics Co's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For BrightPath Biotherapeutics Co (TSE:4594), the current Other Stockholders Equity is 円20.27 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BrightPath Biotherapeutics Co Business Description

Address 2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
34GF Score

Get the complete analysis for TSE:4594

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円51.00
Price